Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Operating Expenses (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Operating Expenses for 3 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 39.45% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.3 million through Dec 2025, down 7.7% year-over-year, with the annual reading at $23.9 million for FY2025, 20.56% down from the prior year.
  • Operating Expenses hit $7.0 million in Q4 2025 for Incannex Healthcare, up from $6.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $9.8 million in Q2 2024 to a low of $4.9 million in Q3 2023.
  • Historically, Operating Expenses has averaged $6.8 million across 3 years, with a median of $6.9 million in 2025.
  • Biggest five-year swings in Operating Expenses: tumbled 37.17% in 2024 and later soared 39.45% in 2025.
  • Year by year, Operating Expenses stood at $8.0 million in 2023, then crashed by 37.17% to $5.0 million in 2024, then skyrocketed by 39.45% to $7.0 million in 2025.
  • Business Quant data shows Operating Expenses for IXHL at $7.0 million in Q4 2025, $6.8 million in Q3 2025, and $7.5 million in Q2 2025.